ONC Q4 2022 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q4 2022 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$380M+77.6% YoY

Gross Profit

$307M80.7% margin

Operating Income

-$469M-123.3% margin

Net Income

-$445M-117.2% margin

EPS (Diluted)

$-30.55

QoQ Revenue Growth

-1.9%

Cash Flow

Operating Cash Flow

-$318M

Free Cash Flow

-$488M

Stock-Based Comp.

$78M

Balance Sheet

Total Assets

$6.4B

Total Liabilities

$2.0B

Stockholders' Equity

$4.4B

Cash & Equivalents

$3.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$380M	$214M	+77.6%
Gross Profit	$307M	$165M	+85.3%
Operating Income	-$469M	-$572M	+18.0%
Net Income	-$445M	-$586M	+24.0%